WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA) and Morgan Griffith (R-VA) today released the following statement regarding a forthcoming Government Accountability Office (GAO) report on Vision Benefit Managers (VBMs):
“We’re happy to hear GAO is nearing completion of its work detailing the growing abuses of Vision Benefit Managers. Since GAO was first tasked with this project… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today celebrated the Food and Drug Administration’s (FDA) decision to accept for review the resubmission of the New Drug Application for Stealth Biotherapeutics’ Barth Syndrome treatment elamipretide, with the goal of reaching a decision by September 26, 2025.
This comes after Rep. Carter sent a letter advocating for the FDA to… Read more »
AUGUSTA – Rep. Earl L. “Buddy” Carter (R-GA) this week met with officials at Augusta University to discuss his advocacy for the Medical College of Georgia (MCG), including the $1 million he secured in FY23 to support the College’s Center for Digital Health.
From Left to Right: David Hess, MD, Dean of Medical College of Georgia; Rep. Buddy Carter (GA-01); and Matt Lyon, MD, Director… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today launched the American-Made Medicines Caucus, a group focused on promoting policies to onshore and friendshore pharmaceutical manufacturing, strengthen our economic and national security interests, and reduce America’s reliance on adversarial countries for essential medications.
The United States is dependent on imports for… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today introduced the FDA Modernization Act 3.0, alongside bipartisan colleagues Reps. Nanette Barragán (D-CA), Vern Buchanan (R-FL), Rosa DeLauro (D-CT), Diana Harshbarger (R-TN), and Troy Carter (D-LA), a bill directing the FDA to fully implement provisions intended to reduce unnecessary animal testing for drug… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Shomari C. Figures (D-AL), Michael Rulli (R-OH), and Kim Schrier, M.D. (D-WA) today introduced the Improving Care in Rural America Reauthorization Act of 2025, a bill extending critical programs that increase access to health care services in rural communities.
Rural residents often encounter barriers to accessing health care,… Read more »
WASHINGTON, D.C. – Rep. Earl L. "Buddy" Carter (R-GA), Chairman of the Subcommittee on Health, delivered the following opening statement at today’s hearing titled Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs.
… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Diana DeGette (D-CO), Kat Cammack (R-FL), Kathy Castor (D-FL), Ryan Mackenzie (R-PA), and Robin Kelly (D-IL) today introduced the Preventing Maternal Deaths Reauthorization Act of 2025.
This bill would assist states in preserving maternal health throughout pregnancy, childbirth, and postpartum, addressing disparities in maternal… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA) and Yvette Clarke (D-NY) introduced the bipartisan Dental and Optometric Care Access (DOC Access) Act to help lower dental and vision care costs and put control of important health care decisions back into the hands of patients and their doctors.
The legislation addresses the increased consolidation and vertical… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA) and Ron Estes (R-KS) today introduced the HEALTH Panel Act, a bill strengthening congressional oversight of, and statutory authority for, the Congressional Budget Office’s (CBO) Panel of Health Advisers.
The bill will help improve the accuracy of CBO’s scores on bills related to health care by codifying the Panel of Health… Read more »
